Arnaud GRANDEURY
14Patents
2h-index
27Co-inventors
50Inventor score
Filing activity: Mar 25, 2011 → Dec 11, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11407735B2 | Crystalline forms of N-[4-(Chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide | Chemistry; Metallurgy | 2 | Active |
| US10799506B2 | Ribociclib tablet | Human Necessities | 2 | Active |
| US8933108B2 | Benzothiazolone compound | Emerging Cross-Sectional Technologies | 1 | Active |
| US12064434B2 | Ribociclib tablet | Human Necessities | 1 | Active |
| US9623012B2 | Formulation comprising benzothiazolone compound | Human Necessities | 1 | Active |
| US12419894B2 | Ribociclib tablet | Human Necessities | 0 | Active |
| US10934273B2 | Crystalline forms of 4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzothiazol-6-yloxy)-N-methylpicolinamide | Chemistry; Metallurgy | 0 | Active |
| US8884014B2 | Method for purifying a fused pyrrolocarbazole derivative | Human Necessities | 0 | Active |
| US12390468B2 | Crystalline forms of a succinate salt of 7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide | Chemistry; Metallurgy | 0 | Active |
| US9913828B2 | Benzothiazolone compound | Emerging Cross-Sectional Technologies | 0 | Active |
| US12252479B2 | Crystalline forms OF N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide | Chemistry; Metallurgy | 0 | Active |
| US8987448B2 | Preparation of anhydrous and hydrated polymorphs 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-YL)-1H-benzimidazol-2-YL]-1H-quinolin-2-one-lactic acid salt | Human Necessities | 0 | Active |
| US12252478B2 | Crystalline forms of N-[4-(chlorodifluoromethoxy)phenyl]-6-[(3R)-3-hydroxypyrrolidin-1-yl]-5-(1H-pyrazol-5-yl)pyridine-3-carboxamide | Chemistry; Metallurgy | 0 | Active |
| US10251868B2 | Benzothiazolone compound | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.